Who should not take PT-141? People with uncontrolled high blood pressure or heart disease should avoid it, along with men and postmenopausal women.
People with uncontrolled high blood pressure or a history of cardiovascular disease should not take PT-141. The only FDA-approved form of the drug, bremelanotide (brand name Vyleesi), is indicated for premenopausal women with hypoactive sexual desire disorder, which leaves men, postmenopausal women, and anyone under 18 outside the approved population. PT-141 is not an FDA-approved treatment for erectile dysfunction.
Who Should Not Take PT-141?
The label lists two hard contraindications, and several other groups fall outside approved use. Here is the short version.
- Uncontrolled hypertension. PT-141 can push blood pressure up temporarily, and that risk is not acceptable when pressure is already high.
- Known cardiovascular disease. A history of heart attack, stroke, chest pain, or an arrhythmia rules out the drug.
- Men. Vyleesi is approved only for premenopausal women, and no male indication has been cleared by regulators.
- Postmenopausal women. Clinical trials enrolled premenopausal women, so safety and effectiveness after menopause are unknown.
- Pregnant or breastfeeding women. There are no adequate human data, so use should be avoided.
- Anyone under 18. No studies support use in children or adolescents.
| Group or condition | Why PT-141 is not advised |
|---|---|
| Uncontrolled high blood pressure | Contraindicated; the drug raises blood pressure transiently |
| Heart attack, stroke, chest pain, arrhythmia history | Contraindicated in known cardiovascular disease |
| Men | Not FDA-approved; male efficacy and safety data are limited |
| Postmenopausal women | Not studied in this population and not indicated |
| Pregnancy or breastfeeding | No adequate human safety data |
| Under 18 years old | Not studied in minors |
Why Blood Pressure and Heart History Matter Most
Bremelanotide causes a short-lived rise in blood pressure that typically appears within a few hours of dosing. That effect is the main reason the FDA contraindicates the drug in people whose hypertension is not controlled or who already have cardiovascular disease.
Nausea is the most common side effect, reported by roughly 40% of participants in clinical trials. Flushing, headache, and injection-site reactions are also frequent.
Repeated use has been linked to focal hyperpigmentation, a darkening of the skin, gums, or breasts that may not fade after the drug is stopped. Anyone who notices new discoloration should speak with a clinician.
Off-Label Use, Men, and Unapproved Products
A frequent question is do you need a prescription for pt-141, and for the FDA-approved product the answer is yes. Vyleesi is prescription-only in the United States, and there is no over-the-counter version.
Because men often cannot obtain a legal prescription, searches for where to buy pt-141 frequently lead to research-chemical vendors. Those products are not inspected for purity or dose accuracy, and users rarely know what they are actually injecting.
If you are comparing delivery routes, pt-141 nasal spray vs injection is a common question. Only the subcutaneous injection is approved, and nasal products sold online have no standardized absorption or dosing.
Dosing Rules and What to Expect
Guidance on how to take pt-141 for the approved product is specific: 1.75 mg injected under the skin of the abdomen or thigh at least 45 minutes before anticipated sexual activity. The limit is one dose every 24 hours and no more than eight doses per month.
People often wonder how long does pt-141 last; the half-life is roughly 2.7 hours, and most users report that effects fade within a few hours of dosing.
A high-fat meal eaten close to dosing can slow absorption and make nausea worse, so timing matters.
Medication Interactions to Keep in Mind
Bremelanotide slows stomach emptying, which can change how quickly oral medications are absorbed. That matters most for drugs with a narrow therapeutic window.
Anyone taking blood pressure medication still should not use PT-141 if their pressure is not controlled. Combining the two does not cancel out the cardiovascular risk.
Tell your prescriber about every prescription, supplement, and recreational substance you use before starting treatment.
Talk With a Clinician First
PT-141 is a prescription drug in the United States, and buying it from an unverified source is risky. A licensed healthcare professional can review your blood pressure, heart history, and medications.
If you have any cardiovascular condition, uncontrolled hypertension, or you are pregnant or breastfeeding, do not use PT-141. Ask about alternatives that are safer for your situation.
Report severe or persistent vomiting, chest pain, or a sudden severe headache to a medical professional right away.
Frequently Asked Questions
Who should not take PT-141?
People with uncontrolled high blood pressure or known cardiovascular disease should not take PT-141, because the drug raises blood pressure temporarily. Vyleesi is also not approved for men, postmenopausal women, pregnant or breastfeeding women, or anyone under 18. Anyone in those groups should discuss other options with a healthcare provider.
Can men use PT-141?
PT-141 is not FDA-approved for men. Vyleesi is indicated only for premenopausal women with hypoactive sexual desire disorder, and male safety and efficacy data are limited. Men who use it are dosing off-label and take on the same cardiovascular risks without a cleared benefit.
Is it safe to buy PT-141 online?
No. PT-141 is prescription-only in the United States, and products sold by research-chemical vendors are not checked for purity, potency, or sterility. Unverified vials can contain the wrong dose or contaminants, so obtaining the drug through a licensed clinician is the safer route.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.